“…Alzheimer’s disease (AD) and behavioral variant frontotemporal dementia (bvFTD) are among the most prevalent neurodegenerative diseases, each linked to specific pathophysiology and to highly heterogeneous and atypical manifestation, hindering detection and diagnosis ( Musa et al, 2020 ; Parra et al, 2018 ). Neuroimaging methods such as positron emission tomography (PET) ( Engler et al, 2008 ; Foster et al, 2007 ; Jack et al, 2018 ; Mosconi et al, 2008 ; Nordberg, 2004 ), functional magnetic resonance imaging (fMRI) ( Hafkemeijer et al, 2015 ; Jalilianhasanpour et al, 2019 ; Moguilner et al, 2021 ), and electroencephalography (EEG) Dottori et al, 2017 ; Lindau et al, 2003 ; Nishida et al, 2013 ; Nishida et al, 2011 ; Cruzat et al, 2023 have been employed extensively to profile these diseases based on their underlying whole-brain activity patterns, and to develop automated classifiers capable of assisting clinical decision-making ( Kim et al, 2019 ; Moguilner et al, 2021 ; Herzog et al, 2022 ). In spite of these advances, the limited knowledge of the large-scale network mechanisms of neurodegenerative dementias hinders the development of interventions oriented to improve brain health and subjective well-being.…”